|
INOTIV, INC. (NOTV) Avaliação DCF
US | Healthcare | Medical - Diagnostics & Research | NASDAQ
|
- ✓ Totalmente Editável: Adapte-Se Às Suas Necessidades No Excel Ou Planilhas
- ✓ Design Profissional: Modelos Confiáveis E Padrão Da Indústria
- ✓ Pré-Construídos Para Uso Rápido E Eficiente
- ✓ Não É Necessária Experiência; Fácil De Seguir
Inotiv, Inc. (NOTV) Bundle
Explore INOTIV, Inc. (NOTV) Perspectivas financeiras com nossa calculadora DCF amigável! Digite suas suposições de crescimento, margens e custos para calcular o valor intrínseco INOTIV, Inc. (NOTV) e moldar sua abordagem de investimento.
Discounted Cash Flow (DCF) - (USD MM)
| Year | AY1 2020 |
AY2 2021 |
AY3 2022 |
AY4 2023 |
AY5 2024 |
FY1 2025 |
FY2 2026 |
FY3 2027 |
FY4 2028 |
FY5 2029 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 60.5 | 89.6 | 547.7 | 572.4 | 490.7 | 660.6 | 889.2 | 1,196.9 | 1,611.2 | 2,168.8 |
| Revenue Growth, % | 0 | 48.18 | 511.19 | 4.52 | -14.27 | 34.61 | 34.61 | 34.61 | 34.61 | 34.61 |
| EBITDA | 1.0 | 15.4 | -273.4 | -26.5 | -26.8 | -54.4 | -73.2 | -98.5 | -132.6 | -178.6 |
| EBITDA, % | 1.7 | 17.15 | -49.93 | -4.63 | -5.45 | -8.23 | -8.23 | -8.23 | -8.23 | -8.23 |
| Depreciation | 5.0 | 7.6 | 49.3 | 54.7 | 57.1 | 61.9 | 83.4 | 112.2 | 151.1 | 203.3 |
| Depreciation, % | 8.24 | 8.44 | 9.01 | 9.56 | 11.64 | 9.38 | 9.38 | 9.38 | 9.38 | 9.38 |
| EBIT | -4.0 | 7.8 | -322.7 | -81.2 | -83.9 | -116.3 | -156.6 | -210.8 | -283.7 | -381.9 |
| EBIT, % | -6.54 | 8.71 | -58.93 | -14.19 | -17.09 | -17.61 | -17.61 | -17.61 | -17.61 | -17.61 |
| Total Cash | 1.4 | 138.9 | 18.5 | 35.5 | 21.4 | 153.6 | 206.8 | 278.3 | 374.7 | 504.3 |
| Total Cash, percent | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 |
| Account Receivables | 10.8 | 28.4 | 100.1 | 90.4 | 73.6 | 130.3 | 175.4 | 236.1 | 317.8 | 427.7 |
| Account Receivables, % | 17.9 | 31.65 | 18.27 | 15.8 | 14.99 | 19.72 | 19.72 | 19.72 | 19.72 | 19.72 |
| Inventories | .7 | .6 | 71.4 | 56.1 | 18.2 | 37.5 | 50.5 | 67.9 | 91.4 | 123.1 |
| Inventories, % | 1.16 | 0.67184 | 13.04 | 9.8 | 3.7 | 5.68 | 5.68 | 5.68 | 5.68 | 5.68 |
| Accounts Payable | 3.2 | 6.2 | 28.7 | 32.6 | 33.5 | 39.5 | 53.2 | 71.6 | 96.4 | 129.8 |
| Accounts Payable, % | 5.29 | 6.88 | 5.24 | 5.69 | 6.83 | 5.98 | 5.98 | 5.98 | 5.98 | 5.98 |
| Capital Expenditure | -6.2 | -12.5 | -36.3 | -27.5 | -22.3 | -53.0 | -71.4 | -96.1 | -129.4 | -174.2 |
| Capital Expenditure, % | -10.25 | -13.92 | -6.63 | -4.8 | -4.55 | -8.03 | -8.03 | -8.03 | -8.03 | -8.03 |
| Tax Rate, % | 17.07 | 17.07 | 17.07 | 17.07 | 17.07 | 17.07 | 17.07 | 17.07 | 17.07 | 17.07 |
| EBITAT | -4.1 | 13.9 | -308.8 | -68.7 | -69.6 | -107.8 | -145.1 | -195.3 | -262.9 | -353.8 |
| Depreciation | ||||||||||
| Changes in Account Receivables | ||||||||||
| Changes in Inventories | ||||||||||
| Changes in Accounts Payable | ||||||||||
| Capital Expenditure | ||||||||||
| UFCF | -13.6 | -5.5 | -415.8 | -12.7 | 21.0 | -168.9 | -177.5 | -238.9 | -321.6 | -432.9 |
| WACC, % | 66.89 | 66.89 | 64.77 | 59.31 | 58.48 | 63.27 | 63.27 | 63.27 | 63.27 | 63.27 |
| PV UFCF | ||||||||||
| SUM PV UFCF | -307.5 | |||||||||
| Long Term Growth Rate, % | 2.00 | |||||||||
| Free cash flow (T + 1) | -442 | |||||||||
| Terminal Value | -721 | |||||||||
| Present Terminal Value | -62 | |||||||||
| Enterprise Value | -370 | |||||||||
| Net Debt | -6 | |||||||||
| Equity Value | -364 | |||||||||
| Diluted Shares Outstanding, MM | 26 | |||||||||
| Equity Value Per Share | -14.04 |
What You Will Receive
- Pre-Filled Financial Model: Inotiv, Inc.'s (NOTV) actual data provides an accurate DCF valuation.
- Comprehensive Forecast Control: Modify revenue growth, profit margins, WACC, and other essential metrics.
- Real-Time Calculations: Automatic updates let you view results instantly as you make adjustments.
- Investor-Ready Template: A polished Excel file crafted for professional-grade valuation.
- Customizable and Reusable: Designed for versatility, enabling repeated use for in-depth forecasts.
Key Features
- Customizable Financial Inputs: Adjust essential metrics such as revenue growth, EBITDA %, and capital investments.
- Instant DCF Valuation: Quickly computes intrinsic value, NPV, and other financial metrics.
- High-Precision Accuracy: Leverages Inotiv's real-world financial data for dependable valuation results.
- Streamlined Scenario Analysis: Effortlessly evaluate various assumptions and analyze outcomes.
- Efficiency Booster: Remove the hassle of constructing intricate valuation models from the ground up.
How It Works
- Step 1: Download the Excel file for Inotiv, Inc. (NOTV).
- Step 2: Review Inotiv's pre-filled financial data and forecasts.
- Step 3: Modify key inputs such as revenue growth, WACC, and tax rates (highlighted cells).
- Step 4: Observe the DCF model update in real-time as you adjust your assumptions.
- Step 5: Analyze the outputs and leverage the results for your investment decisions.
Why Choose Inotiv, Inc. (NOTV)?
- Streamlined Processes: Simplify your research with our ready-to-use solutions.
- Enhanced Accuracy: Dependable data and methodologies ensure precise results.
- Customizable Solutions: Adapt our services to match your unique needs and forecasts.
- User-Friendly Interface: Intuitive design and visualizations facilitate easy data interpretation.
- Preferred by Professionals: Our tools are crafted for experts who prioritize reliability and effectiveness.
Who Should Use Inotiv, Inc. (NOTV)?
- Investors: Gain insights into the biotech sector with a reliable investment analysis tool.
- Financial Analysts: Streamline your workflow with a comprehensive model tailored for biotech evaluations.
- Consultants: Effortlessly customize reports and presentations for clients in the life sciences industry.
- Biotech Enthusiasts: Enhance your knowledge of industry trends and company performance through detailed analyses.
- Educators and Students: Utilize it as a hands-on resource in courses focused on biotechnology and finance.
What the Template Contains
- Comprehensive DCF Model: Editable template with detailed valuation calculations tailored for Inotiv, Inc. (NOTV).
- Real-World Data: Inotiv’s historical and projected financials preloaded for thorough analysis.
- Customizable Parameters: Adjust WACC, growth rates, and tax assumptions to explore various scenarios.
- Financial Statements: Complete annual and quarterly breakdowns for enhanced insights.
- Key Ratios: Integrated analysis for profitability, efficiency, and leverage metrics.
- Dashboard with Visual Outputs: Charts and tables for clear and actionable results specific to Inotiv, Inc. (NOTV).
Disclaimer
All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.
We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.
All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.